List of Oncology Medication For

Solid Tumors

Treatment for solid tumors depends on several factors, including the type and stage of the tumor, its location, and the patient’s overall health. Treatment options may include surgery to remove the tumor, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches.

Cabazitaxel Injection

Prostate

cabazitaxel Injection
for intravenous infusion only Initial U.S. Approval: 2010

Cabazitaxel is indicated in combination with prednisone for the treatment of metastatic castration-resistant prostate cancer following docetaxel-based treatment

Facts about cabazitaxel Injection

Approval Date: 2010
Proprietary Name: On Request
Active Ingredient(s): cabazitaxel Injection
Dosage Forms And Strengths: Single use vial 60 mg/1.5 mL, supplied with diluent (5.7 mL) for JEVTANA
Company: sanofi-aventis U.S. LLC
Current indications: prostate cancer
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import cabazitaxel Injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Calcort (deflazacort)

Neuro

Calcort (deflazacort)

Calcort (deflazacort) is a medication used for the treatment of several conditions, e.g. asthma, arthritis, and allergies, skin, kidney, heart, digestive system, eye and blood conditions, and tumours. Calcort (deflazacort) is also used for the treatment of Duchenne muscular dystrophy (DMD).

Brand Name:	Calcort
Generic Name:	deflazacort
Strength:
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Calcort (deflazacort)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Calcort (deflazacort) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Capecitabine tablets

Colon, Bile Duct Cancer, Breast Cancer, Esophageal, Pancreatic, Stomach

Capecitabine tablets
for oral use Initial U.S. Approval: 1998

capecitabine is a nucleoside metabolic inhibitor with antineoplastic activity indicated for: • Adjuv ant Colon Cancer –Patients with Dukes’ C colon cancer • Metastatic Colorectal Cancer –First-line as monotherapy when treatment with fluoropyrimidine therapy alone is preferred • Metastatic Breast Cancer –In combination with docetaxel after failure of prior anthracyclinecontaining therapy –As monotherapy in patients resistant to both paclitaxel and an anthracycline-containing regimen

Facts about capecitabine tablets

Approval Date: 1998
Proprietary Name: On Request
Active Ingredient(s): capecitabine tablets
Dosage Forms And Strengths: Tablets: 150 mg and 500 mgTablets: 150 mg and 500 mg
Company: Genentech
Current indications: Breast cancer, Colorectal cancer, Pancreatic adenocarcinoma, Stomach (gastric) cancer, esophageal cancer, or gastroesophageal junction cancer in adults, Stomach (gastric) cancer or gastroesophageal junction cancer in adults.
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import capecitabine tablets” based on the information you provide.

Capivasertib Tablets, for oral use Initial U.S. Approval: 2023

Breast Cancer

Capivasertib Tablets, for oral use Initial U.S. Approval: 2023

Truqap is used to treat breast cancers that are:

metastatic and have grown after treatment with at least one hormonal therapy medicine.
locally advanced and have grown within the year after adjuvant treatment was complete; adjuvant treatments are treatments given after breast cancer surgery.

Approval Date: 2023
Proprietary Name: TRUQAP
Active Ingredient(s): capivasertib
FDA-approved use: To treat patients with HER2-negative breast cancer
Dosage Form: Tablets
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Capivasertib Tablets” based on the information you provide.

Capmatinib Tablets

Lung Cancer

capmatinib tablets,
for oral use Initial U.S. Approval: 2020

Tabrecta (capmatinib) is a medication used for the treatment of adults with metastatic NSCLC with a mutation that leads to MET exon 14 skipping (METex14).

Facts about capmatinib tablets

Disease Indications-Lung Cancer
Manufacturer-Novartis Pharmaceuticals Corporation
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Pharmaceuticals and Medical Devices Agency (PMDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “capmatinib tablets” based on the information you provide.

CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine)

Lung Cancer, Pneumonia

Brand Name: CAPVAXIVE . Generic Name: (Pneumococcal 21-valent Conjugate Vaccine). It is used to treat pneumonia.

Capvaxive is a vaccine to protect adults against pneumonia (infection of the lungs) and invasive diseases caused by the bacterium Streptococcus pneumoniae (S. pneumoniae).

Brand Name:	CAPVAXIVE
Generic Name:	Pneumococcal 21-valent Conjugate Vaccine
Strength:	•
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Cemiplimab-rwlc Injection

Lung Cancer, Skin

cemiplimab-rwlc injection
for intravenous use Initial U.S. Approval: 2018

Libtayo (cemiplimab) is a medication used for the treatment of advanced cutaneous squamous cell carcinoma (CSCC), advanced basal cell carcinoma (BCC) and advanced non-small cell lung cancer (NSCLC).

Facts about cemiplimab-rwlc injection

Disease Indications-Lung Cancer, Skin Cancer
Manufacturer-Sanofi
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Cemiplimab-rwlc Injection” based on the information you provide.

COBENFY (xanomeline and trospium chloride) capsules

Neuro, Brain Tumor, Disorders, Solid Tumors

Brand Name: COBENFY Generic Name: xanomeline and trospium chloride . COBENFY (xanomeline and trospium chloride) is used to treat schizophrenia in adults.

FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia. The U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.

Brand Name:	COBENFY
Generic Name:	xanomeline and trospium chloride
Strength:	Capsules (xanomeline/trospium chloride): 50 mg/20 mg, 100 mg/20 mg, 125 mg/30 mg
Manufacturer:	Bristol-Myers Squibb
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “COBENFY (xanomeline and trospium chloride)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for COBENFY (xanomeline and trospium chloride) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Cobimetinib tablets

Skin

cobimetinib tablets
for oral use Initial U.S. Approval: 2015

Cobimetinib is an anti-cancer medication used in combination with vemurafenib (Zelboraf) alone or with both vemurafenib and atezolizumab (Tecentriq) to treat melanoma.

Facts about cobimetinib tablets

DISEASE INDICATIONS-Skin Cancer
MANUFACTURER-Roche Registration GmbH
USAGE-Oral
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA),Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “cobimetinib tablets” based on the information you provide.

COLUMVI (glofitamab-gxbm) injection

Blood Disorders, Lymphoma

Brand Name: COLUMVI. Generic Name: glofitamab-gxbm. It is used to treat blood cancer called diffuse large B-cell lymphoma (DLBCL).

Columvi is a cancer medicine used to treat adults with a blood cancer called diffuse large B-cell lymphoma (DLBCL) whose cancer has returned (relapsed) or stopped responding (refractory) after at least two previous treatments.

Brand Name:	COLUMVI
Generic Name:	glofitamab-gxbm
Strength:	Injection: • 2.5 mg/2.5 mL (1 mg/mL) in a single-dose vial. • 10 mg/10 mL (1 mg/mL) in a single-dose vial.
Manufacturer:	Genentech
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “COLUMVI (glofitamab-gxbm) injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for COLUMVI (glofitamab-gxbm) injection price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Solid Tumors

cabazitaxel Injection for intravenous infusion only Initial U.S. Approval: 2010

Facts about cabazitaxel Injection

Access the best support services globally

Calcort (deflazacort)

Capecitabine tablets for oral use Initial U.S. Approval: 1998

Facts about capecitabine tablets

Access the best support services globally

Capivasertib Tablets, for oral use Initial U.S. Approval: 2023

Access the best support services globally

capmatinib tablets, for oral use Initial U.S. Approval: 2020

Access the best support services globally

Brand Name: CAPVAXIVE . Generic Name: (Pneumococcal 21-valent Conjugate Vaccine). It is used to treat pneumonia.

cemiplimab-rwlc injection for intravenous use Initial U.S. Approval: 2018

Facts about cemiplimab-rwlc injection

Access the best support services globally

Brand Name: COBENFY Generic Name: xanomeline and trospium chloride . COBENFY (xanomeline and trospium chloride) is used to treat schizophrenia in adults.

cobimetinib tablets for oral use Initial U.S. Approval: 2015

Facts about cobimetinib tablets

Access the best support services globally

Brand Name: COLUMVI. Generic Name: glofitamab-gxbm. It is used to treat blood cancer called diffuse large B-cell lymphoma (DLBCL).

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

cabazitaxel Injection
for intravenous infusion only Initial U.S. Approval: 2010

Capecitabine tablets
for oral use Initial U.S. Approval: 1998

capmatinib tablets,
for oral use Initial U.S. Approval: 2020

cemiplimab-rwlc injection
for intravenous use Initial U.S. Approval: 2018

cobimetinib tablets
for oral use Initial U.S. Approval: 2015